Deltex “Celebrating Success” in Edinburgh on Friday

This Friday (Nov 22nd) sees Deltex Medical heading to Edinburgh to participate in “Celebrating Success in Perioperative Care.” The event, held under the auspices of The Enhanced Recovery after Surgery Society…

Fill the Tank, Optimise Flow, Maintain Pressure: Interview at ASA Congress

Anesthesiology 2019 (#ANES19), which took place last weekend in Orlando, was also the venue for an interview with top anaesthesiologist, Prof. Michael Scott from Virginia Commonwealth University (VCU) Hospital. Click…

Deltex Heading to ASA with a Spring in its Step

Buoyed by a raft of recent good news, Deltex Medical is once again exhibiting at the forthcoming Anesthesiology Society of America (ASA) annual congress in Orlando, Florida. The event takes…

Innovate UK Smart Award

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”) has announced that its wholly owned UK subsidiary, Deltex Medical Limited, has been awarded a grant…

Deltex Medical Receives Innovative Technology Contract From Major US Healthcare Consultancy

Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has received an Innovative Technology contract from Vizient, Inc., the largest member-driven healthcare performance improvement company in the…

Oesophageal Doppler Features Strongly in Updated Cancer Surgery Guidance

The UK’s National Institute for Health and Care Excellence (NICE) has updated its guidance for practitioners in the management of colorectal cancer. NICE publishes it’s so-called “pathways” in order to…

Deltex Medical’s Haemodynamic Management Tools at Euroanaesthesia

This weekend sees Vienna hosting the annual Euroanaesthesia event, recognised worldwide as one of the most important and influential congresses in anaesthesiology. With over 6000 international delegates and 100+ exhibitors from…

Deltex CEO Andy Mears to present at Turner Pope investment evening, May 13

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), is pleased to announce that Andy Mears, the Company’s Chief Executive Officer, will be presenting at an investor evening…

Deltex Medical 2018 Results

Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has announced its audited results for the year ended 31 December 2018. Find the link to the…

Pre-Close Statement and Trading Update

Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has published a pre-close statement in relation to the year ended 31 December 2018. The Group has…

Terminus Road | Chichester | PO19 8TX | United Kingdom

  • Enquiries: +44 1243 774837
  • Email: marketing@deltexmedical.com
  • Deltex App:

 

Registered in England & Wales Company No: 1691369